Yi TW, Wong MMY, Neuen BL, Arnott C, et al. Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial. Diabetes Obes Metab 2023;25:2043-2047.
PMID: 36974373